Interestingly, the Notch ligand Jagged1 is also associated with cancer progression; analysis of clinical samples revealed that it is highly expressed in metastatic prostate cancer compared with localised disease (Santagata et al, 2004) and overexpressed in breast cancer patients with poor prognosis (Reedijk et al, 2005). This evidence concerns the gene JAG1 and breast cancer.